Revolutionising cancer treatment, PreTT pioneers best-in-class Pretargeted radioligand therapies, surpassing traditional methods. Our exclusive pretargeting technology is set to transform radioimmunotherapies with monoclonal antibodies (mAbs), making a tangible impact in the fight against cancer.
This company has no org chart yet
This company has no teams yet
This company has no offices yet